We will reach out to you upon commercial availability
Sign up to be the first to know when miLens becomes commercially available.
Be first to know when products launch
Get dedicated support when you onboard
Receive clinical trial results and news
You're on the list. We'll reach out to you when our products become commercially available.
The world's smallest wearable microfluidic device
Current glaucoma management relies on infrequent IOP measurements during office visits, missing critical pressure variations that can lead to irreversible vision loss.
AI-powered remote examination platform
Our Anterior Segment Monitoring Platform provides comprehensive monitoring of all anterior segment conditions including Dry Eye, Cataracts, Conjunctivitis, Blepharitis, Episcleritis, Scleritis, Pterygium, Anterior Uveitis, and Trauma.
Automated micro-dose medication delivery
A novel wearable device that addresses poor medication adherence and imprecise dosing in chronic eye diseases. The automated system delivers personalized micro-dose medications, with initial focus on glaucoma treatment.